【Company Research】Jinxin Fertility (1951 HK) – Better-than-expected recovery from COVID-19 impact |
【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – Maintained dominant position in TAVR market |
【Company Research】I-Mab BioPharma (IMAB US) – Diversified and highly-differentiated pipeline |
【公司研究】广汽集团 (2238 HK) – 埃安混改有序推进,电池技术逐步落地 |
【Company Research】China Pacific Insurance (2601 HK) – Re-energizing agency force |
【Company Research】JNBY Design (3306 HK) – Conservative guidance after a strong result |
【Company Research】JS Global Lifestyle (1691 HK) – Rapid growth and stable margin are achievable |
【公司研究】隆基股份 - A (601012 CH) – 无惧风浪,稳舵前行 |
【Company Research】Sinic Holdings (2103 HK) – Profitability over scale after achieving more balanced land bank |
【公司研究】美东汽车 (1268 HK) – 客户留存项目(CRR)初见成效 |